← All trials
NCT00124358
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2005
- Primary completion
- —
- Completion date
- Dec 1, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 1350
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- The New York Academy of MedicineLead sponsor
- Yale UniversityOverall official - principal investigator
- The New York Academy of MedicineOverall official - principal investigator
- Oregon Health and Science UniversityCollaborator
- University of MiamiCollaborator
- Brown UniversityCollaborator
- University of California, San FranciscoCollaborator
- Johns Hopkins UniversityCollaborator
- Yale UniversityCollaborator
- Yeshiva UniversityCollaborator
- Health Resources and Services Administration (HRSA)Collaborator
- El Rio Santa Cruz Neighborhood Health CenterCollaborator
- Cook County, ILCollaborator
- Organization to Achieve Solutions in Substance AbuseCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.